233
Views
35
CrossRef citations to date
0
Altmetric
Articles

Obidoxime in acute organophosphate poisoning: 2 – PK/PD relationships

, , , , &
Pages 807-813 | Received 25 May 2009, Accepted 24 Jul 2009, Published online: 07 Sep 2009
 

Abstract

Objective. The effects of obidoxime in the treatment of organophosphate poisoning were assessed by biochemical and biological effect monitoring. In this article we report effects on neuromuscular function, oxime and atropine concentration, and relate them to acetylcholinesterase (AChE) activity. Methods. We measured the activity of cholinesterase in plasma and AChE in red blood cells (RBC) and related these data with neuromuscular transmission analysis (ulnar nerve stimulation). Concomitantly, poison and oxon along with plasma obidoxime and atropine levels were measured at regular intervals. Results. We found a close correlation between RBC–AChE activity and neuromuscular transmission and a reciprocal correlation between both the atropine maintenance dose and/or its plasma concentration. The steady state of RBC–AChE activity of reactivation and re-inhibition followed the course predicted by laboratory-determined reaction constants. Conclusions. Intense monitoring of organophosphate-poisoned patients allowed assessment of why a given obidoxime concentration was, or was not, able to counteract the re-inhibition of the RBC–AChE. RBC–AChE activity mirrors the function of n-receptor- and m-receptor-mediated cholinergic signaling as measured by neuromuscular transmission and atropine requirements.

Acknowledgments

The authors thank the ICU staff of the study hospitals for their support; Dr. Michael Haberkorn for his help with neurophysiological examinations; and Christine Diepold, Renate Heilmair, Maria Radtke, and Elisabeth Topoll for technical assistance.

Conflict of interest statement: The study was funded by a Contract-Research-Project (0597-V-4800) for the Bundeswehr Medical Service. The authors have no potentially conflicting financial or institutional interests with the submitted manuscript.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.